Quality Care

Sergio Calvo, general manager of theranostics at GE HealthCare, discusses the organization's use of theranostics in cancer care and how the technology combines targeted therapy with diagnostic imaging for personalized oncology care.

As medical practices seek to implement agentic AI, Michael Clark, OnPoint Healthcare Partners president, recommends constant oversight to ensure agents' work is repeatable, auditable and traceable by a clinical advisory team.

The CEO of NeuroOne, Dave Rosa, discusses the company's minimally invasive brain-computer interface thin-film, flexible electrode technology, its successes in patients with seizures and the potential benefits across a range of neurological conditions.

Deep GI project lead Dr Rungsun Rerknimitr reveals a three-year plan to validate and scale a deployable AI-powered diagnosis system beyond colorectal screening.

Acting assistant under secretary for health at the U.S. Department of Veterans Affairs at the U.S. Department of Veterans Affairs, Dr. Mark Zhang, discusses the VA's research into 3D-printed biological material for veterans.

Also, digital gynaecology clinic Pinky Promise in India has raised $1 million in pre-seed funding.

The investment brings the company's total raise to nearly $700 million.

The $50 million Horizon 1000 pilot initiative will support countries in Africa, beginning in Rwanda, as they work to apply AI technology in their healthcare systems.

Michael Abrams of Numerof and Associates says that oversight for AI used in mental health care should mirror that of pharmaceuticals, with clear standards, safety testing and ongoing monitoring.

Seoul National University Hospital researchers have developed an AI model that predicts the response to an anticonvulsant drug.